IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27 December 2024.Powered by Capital Market - Live News

The Board of IOL Chemicals & Pharmaceuticals will meet on 27 December 2024 to consider and approve the alteration in the share capital of the Company by sub-division / split of existing equity shares having face value of Rs. 10 each. Powered by Capital Market - Live News

Net profit of IOL Chemicals & Pharmaceuticals declined 49.43% to Rs 19.15 crore in the quarter ended September 2024 as against Rs 37.87 crore during the previous quarter ended September 2023. Sales declined 3.59% to Rs 525.75 crore in the quarter ended September 2024 as against Rs 545.30 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales525.75545.30 -4 OPM %7.9111.77 - PBDT43.8866.87 -34 PBT25.9451.18 -49 NP19.1537.87 -49 Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Net profit of IOL Chemicals & Pharmaceuticals declined 34.65% to Rs 29.97 crore in the quarter ended June 2024 as against Rs 45.86 crore during the previous quarter ended June 2023. Sales declined 10.80% to Rs 502.38 crore in the quarter ended June 2024 as against Rs 563.18 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales502.38563.18 -11 OPM %10.1712.88 - PBDT56.3475.63 -26 PBT39.5261.18 -35 NP29.9745.86 -35 Powered by Capital Market - Live News